Literature DB >> 11215225

[Relief of subacute herpetic pain and postherpetic neuralgia with repeated application of 10% lidocaine cream].

M Iseki1, H Mitsuhata, T Miyazaki, E Toriumi, K Yoshino.   

Abstract

Analgesic efficacy of repeated application of a lidocaine cream formula was investigated in herpes zoster patients with subacute pain with no further improvement after continued treatment since their acute stage (S-HZ group, n = 23), and in patients to whom past treatments had not provided adequate pain relief (PHN group, n = 28). In both groups, visual analog scale (VAS) values decreased significantly from their corresponding values before the present treatment with few cases of side effects and complete disappearances of the pain in 21.6% of all the patients. The results indicate that the repeated application of the lidocaine cream is a safe and effective treatment method. Significantly higher effectiveness was achieved in the S-HZ group in terms of the difference in the VAS values between before and after the treatment, effectiveness in improving the activities of daily life, and overall efficacy evaluation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11215225

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  3 in total

Review 1.  WITHDRAWN: Topical lidocaine for the treatment of postherpetic neuralgia.

Authors:  Waqas Khaliq; Serena Alam; Naveen Kumar Puri
Journal:  Cochrane Database Syst Rev       Date:  2013-10-28

2.  Peripheral nerve block with a high concentration of tetracaine dissolved in bupivacaine for intractable post-herpetic itch: a case report.

Authors:  Daiki Yamanaka; Takashi Kawano; Marie Shigematsu-Locatelli; Atsushi Nishigaki; Sonoe Kitamura; Bun Aoyama; Hiroki Tateiwa; Noriko Kitaoka; Masataka Yokoyama
Journal:  JA Clin Rep       Date:  2016-12-05

Review 3.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.